VALUE OF CLOFIBRATE IN CORONARY HEART-DISEASE

被引：6

作者：

GILLAM, PMS ^{[1
]}

机构：

[1] SALISBURY GEN INFIRM, FISHERTON ST, SALISBURY SP2 7SX, WILTSHIRE, ENGLAND

来源：

关键词：

D O I：

10.1016/0002-8703(74)90382-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 4

页数：4

共 20 条

[1] TRIAL OF CLOFIBRATE
CHAKRABARTI, R
MEADE, TW
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1972, 1 (5794): : 247 - +
[2] Cochrane A.L, 1972, EFFECTIVENESS EFFICI, DOI DOI 10.1016/S0033-3506(73)80082-4
[3] COTTON RC, 1972, ACTA CARDIOL S, V15, P163
[4] SECONDARY PREVENTION TRIALS USING CLOFIBRATE - JOINT COMMENTARY ON NEWCASTLE AND SCOTTISH TRIALS
DEWAR, HA
OLIVER, MF
[J]. BRITISH MEDICAL JOURNAL, 1971, 4 (5790) : 784 - &
[5] DOLLERY CT, 1971, CHALLENGES CHANGE
[6] FISHER RA, 1960, DESIGN OF EXPT
[7] KAKKAR VV, 1971, LANCET, V2, P7726
[8] FACTORS OF RISK IN DEVELOPMENT OF CORONARY HEART DISEASE - 6-YEAR FOLLOW-UP EXPERIENCE
KANNEL, WB
KAGAN, A
STOKES, J
DAWBER, TR
REVOTSKIE, N
[J]. ANNALS OF INTERNAL MEDICINE, 1961, 55 (01) : 33 - +
[9] DIET AND THE EPIDEMIOLOGY OF CORONARY HEART DISEASE
KEYS, A
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 164 (17): : 1912 - 1919
[10] KEYS A, 1970, CIRCULATION, V41, pI1